ReviewAvicenna journal of medicine

Firibastat, the first-in-class brain aminopeptidase a inhibitor, in the management of hypertension: A review of clinical trials.

Sara Abdulrahman Alomar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.